Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its LuerVax ® intranasal ...

Aptar today announced the expansion of its operations in Mumbai, India to add local production of several pharma inhalation technologies, including Aptar’s pressurized metered dose inhaler (pMDI) ...

In today’s regulatory environment, patient safety is a priority, making contamination control and sterility essential in pharmaceutical manufacturing. The latest EMA GMP Annex 1 revision recommends ...

We believe in our people, and do our best to develop their knowledge, skills and abilities. This allows us to help them achieve their potential and ensures that Aptar’s success and growth. Learning ...

Aptar Pharma offers decades of experience in providing customers with technology and scientific service solutions to todays’ nasal drug delivery challenges. With specialized nasal drug delivery ...

Squeeze and Dose is an innovative dosing system designed to elevate the product experience. Engineered for precision and effortless, one-handed operation, it delivers clean, accurate dispensing that ...

Our sustainable product solutions span the beauty, personal and home care, pharmaceutical and food and beverage markets, aiming to reduce our environmental impact, especially with regard to recycling, ...

Aptar Beauty expands its Advance Collection with Novus Advance, a full-polyolefin cosmetic pump for hair and body care that is recyclable in the PET and PE streams when paired with compatible HDPE, PP ...

(Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% to over $1 billion for the first time, and core ...

Crystal Lake, Illinois, April 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the ...

The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment. Aptar Digital Health, a ...

Aptar announced today that it has entered into exclusive negotiations with respect to a potential acquisition of all outstanding shares of Voluntis, a pioneer in digital therapeutics. AptarGroup, Inc.